- Home
- BPOP vs CRL Comparison
BPOP vs CRL Comparison
Compare BPOP & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BPOP | CRL |
|---|---|---|
| Founded | 1893 | 1947 |
| Country | United States | United States |
| Employees | 37 | N/A |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 10.8B |
| IPO Year | 1998 | 1999 |
Fundamental Metrics
Financial Performance| Metric | BPOP | CRL |
|---|---|---|
| Price | $177.69 | $278.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $160.18 | ★ $198.27 |
| AVG Volume (30 Days) | 407.3K | ★ 895.1K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.03% | N/A |
| EPS Growth | ★ 43.69 | N/A |
| EPS | ★ 8.13 | N/A |
| Revenue | $756,100,000.00 | ★ $1,857,601,000.00 |
| Revenue This Year | $12.86 | N/A |
| Revenue Next Year | $5.79 | $3.04 |
| P/E Ratio | $21.88 | ★ N/A |
| Revenue Growth | ★ 16.00 | 10.48 |
| 52 Week Low | $108.74 | $144.26 |
| 52 Week High | $179.14 | $288.02 |
Technical Indicators
Market Signals| Indicator | BPOP | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 64.14 | 74.48 |
| Support Level | $168.72 | $153.47 |
| Resistance Level | $179.00 | N/A |
| Average True Range (ATR) | 3.06 | 9.39 |
| MACD | -0.20 | 3.21 |
| Stochastic Oscillator | 83.55 | 84.23 |
Price Performance
Historical ComparisonAbout BPOP Popular Inc.
Popular Inc, based in Puerto Rico, is a financial holding company with four main subsidiaries: Banco Popular de Puerto Rico, a bank in Puerto Rico in terms of assets; Banco Popular North America, its banking operation in the continental United States; Evertec, a data processor; and Popular Financial Holdings, a diversified financial services company. The Corporation's reportable segments consist of Banco Popular de Puerto Rico and Popular U.S.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.